Hear Vicore Pharma’s CEO, Ahmed Mousa speak to Optimum's Richard Staines on their new treatment for Idiopathic Pulmonary Fibrosis (IPF), C21. It aims to improve available treatments for patients of IPF by halting the progression of fibrosis and has the aim of restoring lung function. <hr> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.

Hear Vicore Pharma’s CEO, Ahmed Mousa speak to Optimum's Richard Staines on their new treatment for Idiopathic Pulmonary Fibrosis (IPF), C21. It aims to improve available treatments for patients of IPF by halting the progression of fibrosis and has the aim of restoring lung function. Hosted on Acast. See acast.com/privacy for more information.

Hear Vicore Pharma’s CEO, Ahmed Mousa speak to Optimum's Richard Staines on their new treatment for Idiopathic Pulmonary Fibrosis&nbsp;(IPF), C21. It aims to improve available treatments for patients of IPF by halting the progression of fibrosis and has the aim of restoring lung function. Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer">acast.com/privacy</a> for more information.

Vicore Pharma: Restoring lung function for IPF patients

<a href="https://www.optimumcomms.com/podcast/" rel="noopener noreferrer" target="_blank">Optimum Insights: Interviews with industry leaders of the healthcare sector in regular episodes highlighting the latest innovation and developments in life sciences.</a>Follow us on <a href="https://www.linkedin.com/company/optimum-strategic-communications/" rel="noopener noreferrer" target="_blank">Linkedin</a> and <a href="https://twitter.com/OptimumComms" rel="noopener noreferrer" target="_blank">Twitter</a> for news and highlights on the life sciences industry. Reach out via our contact page on our website: <a href="https://www.optimumcomms.com/" rel="noopener noreferrer" target="_blank">www.optimumcomms.com</a><hr> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.

Business

Science

Health & Fitness

Optimum Insights: Interviews with industry leaders of the healthcare sector in regular episodes highlighting the latest innovation and developments in life sciences. Follow us on Linkedin and Twitter for news and highlights on the life sciences industry. Reach out via our contact page on our website: www.optimumcomms.com Hosted on Acast. See acast.com/privacy for more information.

<a href="https://www.optimumcomms.com/podcast/" rel="noopener noreferrer">Optimum Insights: Interviews with industry leaders of the healthcare sector in regular episodes highlighting the latest innovation and developments in life sciences.</a>Follow us on <a href="https://www.linkedin.com/company/optimum-strategic-communications/" rel="noopener noreferrer">Linkedin</a> and <a href="https://twitter.com/OptimumComms" rel="noopener noreferrer">Twitter</a> for news and highlights on the life sciences industry. Reach out via our contact page on our website: <a href="https://www.optimumcomms.com/" rel="noopener noreferrer">www.optimumcomms.com</a> Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer">acast.com/privacy</a> for more information.

Share Vicore Pharma: Restoring lung function for IPF patients

Sign up to save your podcasts

Vicore Pharma: Restoring lung function for IPF patients

Vicore Pharma: Restoring lung function for IPF patients